Sepsis-3: Insights from the Lead Author

Tipo de sala

Permanente

Nome

Este campo é obrigatório.

Sobrenome

Este campo é obrigatório.

Endereço de e-mail

Este campo é obrigatório.

Empresa

Este campo é obrigatório.

Campos obrigatórios

Pagamento por

Antes de comprar o seu ingresso, por favor confira os requisitos técnicos para participar do evento aqui.

* Caso já tenha se registrado e não consiga localizar seu e-mail de confirmação de registro, clique aqui!

Teste de configuração do sistema. Clique aqui!

Marvyn Singer, MD

Mervyn Singer, MB BS, MD, FRCP (Lon), FRCP (Edin), FFICM, is Professor of Intensive Care Medicine and Director of the Bloomsbury Institute of Intensive Care Medicine at University College London, UK, since 2001. He was Senior Investigator at the National Institute of Health Research from 2009 to 2017 and is currently the Sepsis Topic Advisor for NICE. Dr Singer was Co-chair of the Sepsis-3 Consensus Task Force and lead author of "The Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3).

Pauta do evento

This special session features Dr. Mervyn Singer, lead author of Sepsis-3 guidelines and co-author of the new update to SOFA, SOFA-2.

In this session, Dr. Singer:

Outlines why the Sepsis-2 SIRS criteria are now regarded as outdated and inadequate.
Describes the development process of the Sepsis-3 guidelines.
Discusses the latest revisions to the SOFA score, known as SOFA-2.
Debunks the common sepsis denial rationales presented by payers.

Recording is available for 90 days after purchase.